[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20055563L - Midler for behandlingen av lavere abdominale lidelser - Google Patents

Midler for behandlingen av lavere abdominale lidelser

Info

Publication number
NO20055563L
NO20055563L NO20055563A NO20055563A NO20055563L NO 20055563 L NO20055563 L NO 20055563L NO 20055563 A NO20055563 A NO 20055563A NO 20055563 A NO20055563 A NO 20055563A NO 20055563 L NO20055563 L NO 20055563L
Authority
NO
Norway
Prior art keywords
treatment
lower abdominal
abdominal disorders
disorders
pantoprazole
Prior art date
Application number
NO20055563A
Other languages
English (en)
Inventor
Wolfgang-Alexander Simon
Ursula Hole
Iris Velten
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of NO20055563L publication Critical patent/NO20055563L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfirmelsen vedrører anvendelsen av pantoprazol i behandlingen av lavere abdominale lidelser.
NO20055563A 2003-05-06 2005-11-24 Midler for behandlingen av lavere abdominale lidelser NO20055563L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03010168 2003-05-06
EP03016362 2003-07-19
PCT/EP2004/050694 WO2004098599A2 (en) 2003-05-06 2004-05-04 Proton pump inhibitors for the treatment of lower abdominal disorders

Publications (1)

Publication Number Publication Date
NO20055563L true NO20055563L (no) 2005-11-24

Family

ID=33436110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055563A NO20055563L (no) 2003-05-06 2005-11-24 Midler for behandlingen av lavere abdominale lidelser

Country Status (7)

Country Link
US (1) US20060235053A1 (no)
EP (1) EP1660084A2 (no)
AU (1) AU2004237362A1 (no)
CA (1) CA2524268A1 (no)
MX (1) MXPA05011699A (no)
NO (1) NO20055563L (no)
WO (1) WO2004098599A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
PL1976532T3 (pl) 2006-01-27 2016-05-31 Univ Yale Szybko działający inhibitor wydzielania kwasu żołądkowego
CA2660648A1 (en) * 2006-06-15 2007-12-21 Novartis Ag Compositions and methods for treating diseases
CA2704957A1 (en) * 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
WO2014052625A1 (en) * 2012-09-27 2014-04-03 Levetan Claresa Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
KR940006531B1 (ko) * 1991-08-30 1994-07-21 주식회사 코오롱 피리딘 유도체의 제조방법
JPH08509736A (ja) * 1993-04-27 1996-10-15 セプラコー，インコーポレイテッド 光学的に純粋な（−）パントプラゾールを用いる胃の疾患治療の方法と組成
US6156771A (en) * 1997-08-28 2000-12-05 Rubin; Walter Method for alleviation of lower gastrointestinal disorders in a human patient
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
AU2002366796A1 (en) * 2001-12-19 2003-07-09 Eisai Co. Ltd Methods using proton pump inhibitors

Also Published As

Publication number Publication date
EP1660084A2 (en) 2006-05-31
CA2524268A1 (en) 2004-11-18
MXPA05011699A (es) 2006-01-23
US20060235053A1 (en) 2006-10-19
WO2004098599A2 (en) 2004-11-18
WO2004098599A3 (en) 2005-02-03
AU2004237362A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
NO20072558L (no) Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
TW200510416A (en) P38 inhibitors and methods of use thereof
NO20092637L (no) Fremgangsmater for behandling
NI200600319A (es) Antagonistas de ccr2 de sal cuaternaria
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
GEP20084550B (en) Substituted morpholine compounds for the treatment of central nervous system disorders
NO20071378L (no) Tiazolo-naftylsyrer.
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
NO20065859L (no) Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20054371L (no) Somatostatin-dopamin kimaere analoger
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE494890T1 (de) Alpha-aminoamid-derivate zur behandlung von suchtstörungen
NO20055741D0 (no) Nye kjemiske forbindelser
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
TW200716561A (en) P38 inhibitors and methods of use thereof
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104